scholarly journals Editorial Comment to Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma

2020 ◽  
Vol 3 (5) ◽  
pp. 179-180
Author(s):  
Ario Takeuchi ◽  
Masaki Shiota
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Adverse Events ◽  
Editorial Comment ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Experienced Patient ◽  
Programmed Cell Death 1

scholarly journals Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma

2020 ◽  
Vol 3 (5) ◽  
pp. 176-179 ◽  
Author(s):  
Yoko Maegawa ◽  
Taigo Kato ◽  
Shinichiro Fukuhara ◽  
Hiroshi Kiuchi ◽  
Ryoichi Imamura ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Adverse Events ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Experienced Patient ◽  
Programmed Cell Death 1

scholarly journals Rapidly progressing programmed cell death 1 inhibitor‐related pneumonitis in a hemodialytic patient with metastatic renal cell carcinoma

2019 ◽  
Vol 2 (3) ◽  
pp. 155-157
Author(s):  
Yoshiaki Matsumura ◽  
Yusuke Iemura ◽  
Shinji Fukui ◽  
Yoshihiro Tatsumi ◽  
Yoriaki Kagebayashi ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Programmed Cell Death 1

scholarly journals Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation

Cancer ◽  
2017 ◽  
Vol 123 (24) ◽  
pp. 4823-4831 ◽  
Author(s):  
Fumi Kawakami ◽  
Kanishka Sircar ◽  
Jaime Rodriguez‐Canales ◽  
Bryan M. Fellman ◽  
Diana L. Urbauer ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Death ◽  
Programmed Cell Death ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Infiltrating Lymphocyte
Sign in / Sign up

Export Citation Format

Share Document